The CFO transition is routine and unlikely to drive near-term stock movement. Monitor for any future capital allocation or financing announcements under the new CFO, but no immediate trading catalyst.
Price Chart
Executive Summary
Tenaya Therapeutics announced the appointment of Eric Hyllengren as CFO, effective July 13, 2026, replacing interim CFO Faraz Ali and interim PAO Tomohiro Higa. The press release also noted the planned retirement of SVP Finance Hiro Higa in Q3 2026, which is unrelated to the new hire. This is a routine executive transition with no financial data or material strategic changes.
Key Facts
- Eric Hyllengren appointed CFO, effective July 13, 2026
- Annual base salary of $490,000 with 40% target bonus
- Option to purchase 1,650,000 shares of common stock under 2024 Inducement Plan
- Prior roles include CFO at Zura Bio and CFO/COO at Atara Biotherapeutics
- Tomohiro Higa (SVP Finance) retiring in Q3 2026, will remain as consultant
- No financial results or guidance provided in this filing
Financial Impact
No financial impact disclosed; compensation details for new CFO are standard for a clinical-stage biotech.
Risk Factors
- Potential disruption during finance leadership transition, though overlap and consultant role mitigate this
- No changes to clinical pipeline or financial outlook disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-286957 |
| Document: tnya-ex10_1.htm | 0001193125-26-286957 |
| Document: tnya-ex99_1.htm | 0001193125-26-286957 |
| Document: 0001193125-26-286957-index-headers.html | 0001193125-26-286957 |
| Document: 0001193125-26-286957-index.html | 0001193125-26-286957 |
| Document: 0001193125-26-286957.txt | 0001193125-26-286957 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | DEFA14A | $0.4086 | awaiting T+60 | — | $0.4014 (−1.76%) |
Oct 23, 2026 4d ago | DEF 14A | $0.4086 | awaiting T+60 | — | $0.4014 (+1.76%) |
Aug 17, 2026 10w ago | 144 | $0.6990 | awaiting T+60 | — | $0.4014 (+42.58%) |
Jul 2, 2026 16w ago | 8-K | $0.7869 $0.5898 | ▼ −25.05% | ▼ −28.62% | $0.4014 (−48.99%) |
Jun 29, 2026 17w ago | 8-K | $0.7349 $0.6822 | ▼ −7.17% | ▼ −11.56% | $0.4014 (−45.38%) |
Jun 12, 2026 19w ago | Institutional Cluster | $0.7118 $0.6634 | ▲ +6.80% | ▲ +10.06% | $0.4014 (+43.61%) |
May 29, 2026 21w ago | 8-K | $0.8700 $0.7014 | ▼ −19.38% | ▼ −20.61% | $0.4014 (−53.86%) |
May 19, 2026 22w ago | Insider Cluster | $0.8080 $0.7281 | ▼ −9.89% | ▼ −14.89% | $0.4014 (−50.32%) |
Apr 16, 2026 27w ago | DEFA14A | $0.7470 $0.8365 | ▲ +11.98% | ▲ +4.94% | $0.4014 (−46.27%) |
Mar 11, 2026 32w ago | 8-K | $0.8930 $0.7280 | ▼ −18.48% | ▼ −29.17% | $0.4014 (−55.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers